CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Decidual Stromal Cells (DSC)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (2)


Name (Synonyms) Correlation
drug1739 PLACEBO GROUP Wiki 1.00
drug283 BCG GROUP Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 DSC-COVID-19: An Open-label Study on the Safety and Efficacy of Decidual Stromal Cells in Respiratory Failure Induced by COVID-19

This is a research study to see how safe and effective decidual stromal cells are in treating patients with respiratory failure (breathing problem where not enough oxygen is passed from the lungs into the blood) caused by COVID-19.

NCT04451291 COVID-19 Acute Respiratory Distress Syndrome Biological: Decidual Stromal Cells (DSC)
MeSH:Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Respiratory Insufficiency Acute Lung Injury

Primary Outcomes

Measure: Number of ventilator free days following infusion of decidual stromal cells

Time: 28 days

Secondary Outcomes

Measure: Mortality rate from COVID-19

Time: 28 days

Measure: Mortality rate from COVID-19

Time: 60 days

Measure: Mortality rate from COVID-19

Time: 180 days

Measure: All-cause morality rate

Time: 28 days

Measure: All-cause morality rate

Time: 60 days

Measure: All-cause morality rate

Time: 180 days

Measure: Average number of days in ICU

Time: 180 days

Measure: Average number of days of hospital admittance

Time: 180 days

Measure: Average days not requiring vasopressors

Time: 180 days

Measure: Overall survival rate

Time: 180 days

Measure: Average viral clearance

Time: 180 days

Measure: Average number of days of supplemental oxygenation

Time: 180 days

Measure: Average number of day without supplemental oxygen

Time: 180 days

Measure: Mean PaO2/FiO2 as compared to patient baseline

Time: 180 days


No related HPO nodes (Using clinical trials)